Quantification of antibody-drug conjugate PYX-201 in rat and monkey plasma via ELISA and its application in preclinical studies

被引:7
作者
Yin, Feng [1 ]
DeCiantis, Chris [2 ]
Pinkas, Jan [1 ]
Das, Biplab [1 ]
Wang, Frank [1 ]
Zheng, Nancy [3 ]
Hahn, David [3 ]
Amrite, Aniruddha [1 ]
Adhikari, Diana [1 ]
Kane, Cheikh [2 ]
Sikora, Jack [1 ]
Pittman, Justin [2 ]
Wates, Rebecca [2 ]
Shaheen, Elizabeth [1 ]
Harriman, Shawn [1 ]
机构
[1] Pyxis Oncol Inc, 150 Cambridgepk Dr, Cambridge, MA 02140 USA
[2] KCAS Bioanalyt & Biomarker Serv, 10830 South Clay Blair Blvd, Olathe, KS 66061 USA
[3] Amador Biosci Inc, 4695 Chabot Dr, Pleasanton, CA 94588 USA
关键词
ADC; Aur0101; ELISA; extra domain B fibronectin; oncology; preclinical; PYX-201; toxicokinetic; validation; vc0101; ED-B FIBRONECTIN; EXTRA-DOMAIN B; TARGET; BIOANALYSIS; EXPRESSION; TUMORS;
D O I
10.4155/bio-2022-0233
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Aim: PYX-201 is a novel antibody-drug conjugate targeting the extra domain B splice variant of fibronectin in the tumor microenvironment. Accurate quantification of PYX-201 is critical for PYX-201 pharmacokinetics profiling in preclinical studies. Materials & methods: ELISA was performed using reference standard PYX-201, mouse monoclonal anti-monomethyl auristatin E antibody, mouse IgG1, mouse monoclonal anti-human IgG horseradish peroxidase and donkey anti-human IgG horseradish peroxidase. Results: This assay was validated at 50.0-10,000 ng/ml in rat dipotassium EDTA plasma and 250-10,000 ng/ml in monkey dipotassium EDTA plasma. Conclusion: This is the first time for a PYX-201 bioanalytical assay in any matrix to be reported.
引用
收藏
页码:43 / 52
页数:10
相关论文
共 22 条
[1]  
[Anonymous], 2018, Guidance for Industry: Bioanalytical Method Validation, DOI DOI 10.1164/RCCM.201301-0153OC
[2]  
[Anonymous], 2019, ICH guideline M10 on bioanalytical method validation
[3]   A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis-associated extra type III domain B [J].
Balza, Enrica ;
Sassi, Francesca ;
Ventura, Elisa ;
Parodi, Arianna ;
Fossati, Sara ;
Blalock, William ;
Carnemolla, Barbara ;
Castellani, Patrizia ;
Zardi, Luciano ;
Borsi, Laura .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (04) :751-758
[4]   Multiplex LC-MS/MS Assays for Clinical Bioanalysis of MEDI4276, an Antibody-Drug Conjugate of Tubulysin Analogue Attached via Cleavable Linker to a Biparatopic Humanized Antibody against HER-2 [J].
Faria, Morse ;
Peay, Marlking ;
Lam, Brandon ;
Ma, Eric ;
Yuan, Moucun ;
Waldron, Michael ;
Mylott, William R., Jr. ;
Liang, Meina ;
Rosenbaum, Anton I. .
ANTIBODIES, 2019, 8 (01)
[5]  
Gorovits B, 2013, BIOANALYSIS, V5, P997, DOI [10.4155/BIO.13.38, 10.4155/bio.13.38]
[6]   Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade [J].
Hooper, Andrea T. ;
Marquette, Kimberly ;
Chang, Chao -Pei Betty ;
Golas, Jonathon ;
Jain, Sadhana ;
Lam, My-Hanh ;
Guffroy, Magali ;
Leal, Mauricio ;
Falahatpisheh, Hadi ;
Mathur, Divya ;
Chen, Ting ;
Kelleher, Kerry ;
Khandke, Kiran ;
Muszynska, Elwira ;
Loganzo, Frank ;
Rosfjord, Edward ;
Lucas, Judy ;
Kan, Zhengyan ;
Subramanyam, Chakrapani ;
O'Donnell, Christopher ;
Neri, Dario ;
Gerber, Hans-Peter ;
May, Chad ;
Sapra, Puja .
MOLECULAR CANCER THERAPEUTICS, 2022, 21 (09) :1462-1472
[7]   ED-B fibronectin in non-small cell lung carcinoma [J].
Khan, ZA ;
Caurtero, J ;
Barbin, YP ;
Chan, BM ;
Uniyal, S ;
Chakrabarti, S .
EXPERIMENTAL LUNG RESEARCH, 2005, 31 (07) :701-711
[8]   Evaluation of EDB Fibronectin in Plasma, Patient-Derived Xenograft Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tumor Tissues Using Immunoaffinity LC-MS/MS [J].
Li, Fengping ;
Hooper, Andrea T. ;
Golas, Jonathon ;
Chang, Chao-Pei Betty ;
Neubert, Hendrik ;
King, Lindsay .
JOURNAL OF PROTEOME RESEARCH, 2022, 21 (10) :2331-2340
[9]   抗体偶联药物研发中的生物分析 [J].
李秀立 ;
陈笑艳 ;
钟大放 .
药学学报, 2016, (04) :517-528
[10]   Expression of fibronectin isoforms in human breast tissue:: Production of extra domain A+ extra domain B+ by cancer cells and extra domain A+ by stromal cells [J].
Matsumoto, E ;
Yoshida, T ;
Kawarada, Y ;
Sakakura, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (03) :320-325